The relationships between midline shift, cistern effacement, small vessel disease (old infarcts, van Swieten score) and measures of brain atrophy with MRS at day 90, death at day 4 and acute neurological deterioration
Variable | Day 90 mRS† | Day 4 death | Acute Neurological deterioration* | |||
OR | P value | OR | P value | OR | Pvalue | |
Small vessel disease | ||||||
Old infarcts (yes vs no) | 1.11 (0.39 to 3.16) | 0.84 | 1.80 (0.58 to 5.54) | 0.30 | 0.94 (0.28 to 3.12) | 0.91 |
Leukoaraiosis (per one point increase in van Swieten score) | 0.84 (0.58 to 1.23) | 0.37 | 1.23 (0.83 to 1.82) | 0.29 | 1.16 (0.74 to 1.81) | 0.52 |
Brain atrophy | ||||||
Sylvian Fissure Ratio (per 1% increase) | 1.06 (0.93 to 1.20) | 0.42 | 0.97 (0.86 to 1.10) | 0.68 | 1.07 (0.93 to 1.23) | 0.36 |
Intercaudate distance (per mm increase) | 1.02 (0.96 to 1.08) | 0.53 | 1.03 (0.98 to 1.08) | 0.28 | 1.01 (0.94 to 1.09) | 0.72 |
Cerebral parenchymal volume/Intracranial volume (per 1% increase) | 1.01 (0.97 to 1.05) | 0.70 | 1.00 (0.96 to 1.05) | 0.93 | 1.02 (0.97 to 1.08) | 0.47 |
Comparisons by binary logistic regression shown as OR with 95% CIs, with adjustment for age, sex, GCS, systolic blood pressure, time from stroke onset to CT scan, treatment assignment (GTN vs no GTN) and haemorrhage volume.
*Acute neurological deterioration which was defined as an increase in National Institutes of Health Stroke Scale of ≥4 or a decrease in GCS of ≥2.25
†OR of mRS score >3.
CPV, cerebral parenchymal volume; GCS, Glasgow Coma Scale; GTN, glyceryl trinitrate; ICV, intracranial volume; mRS, modified Rankin scale; SFR, Sylvian fissure ratio.